Multiple Sclerosis
FY20 Ad Hoc Programmatic Reviewers:
Mark Allegretta, Ph.D.
National Multiple Sclerosis Society
Eduard Gappmaier, Ph.D., P.T.
University of Utah
Adam Kaplin, M.D., Ph.D.
MyMD Pharmaceuticals, Inc; Johns Hopkins University School of Medicine
Nancita Rogers
National Multiple Sclerosis Society
Terri Wood, Ph.D.
New Jersey Medical School, Rutgers University
Last updated Thursday, May 26, 2022